MGO One Seven LLC Raises Holdings in Zoetis Inc. $ZTS

MGO One Seven LLC increased its position in Zoetis Inc. (NYSE:ZTS) by 38.7% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 18,313 shares of the company’s stock after purchasing an additional 5,107 shares during the period. MGO One Seven LLC’s holdings in Zoetis were worth $2,680,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Evergreen Private Wealth LLC grew its position in shares of Zoetis by 1.6% during the third quarter. Evergreen Private Wealth LLC now owns 33,450 shares of the company’s stock worth $4,894,000 after acquiring an additional 519 shares during the last quarter. Swmg LLC raised its position in Zoetis by 32.1% in the 3rd quarter. Swmg LLC now owns 2,488 shares of the company’s stock valued at $364,000 after purchasing an additional 604 shares during the last quarter. Associated Banc Corp boosted its stake in Zoetis by 3.8% during the 3rd quarter. Associated Banc Corp now owns 46,624 shares of the company’s stock worth $6,822,000 after purchasing an additional 1,728 shares during the period. Sachetta LLC grew its position in Zoetis by 7.5% during the 3rd quarter. Sachetta LLC now owns 1,288 shares of the company’s stock worth $188,000 after purchasing an additional 90 shares during the last quarter. Finally, MASTERINVEST Kapitalanlage GmbH increased its stake in Zoetis by 12.2% in the third quarter. MASTERINVEST Kapitalanlage GmbH now owns 6,552 shares of the company’s stock valued at $959,000 after purchasing an additional 711 shares during the period. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently weighed in on ZTS. Stifel Nicolaus decreased their target price on shares of Zoetis from $140.00 to $130.00 and set a “hold” rating for the company in a research note on Tuesday, November 18th. BTIG Research reaffirmed a “buy” rating and set a $160.00 price objective on shares of Zoetis in a research report on Wednesday, December 3rd. UBS Group dropped their target price on Zoetis from $158.00 to $141.00 and set a “neutral” rating on the stock in a report on Wednesday, November 5th. JPMorgan Chase & Co. cut their price target on Zoetis from $230.00 to $200.00 and set an “overweight” rating for the company in a research note on Wednesday, November 5th. Finally, Morgan Stanley set a $160.00 price objective on shares of Zoetis in a research report on Thursday, December 18th. Six equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $160.18.

Zoetis Trading Down 0.6%

Shares of ZTS stock opened at $124.60 on Wednesday. The company has a market capitalization of $54.91 billion, a price-to-earnings ratio of 20.98, a PEG ratio of 2.55 and a beta of 0.97. The company has a current ratio of 3.64, a quick ratio of 2.28 and a debt-to-equity ratio of 1.31. The firm has a 50-day moving average price of $122.90 and a 200 day moving average price of $140.04. Zoetis Inc. has a twelve month low of $115.25 and a twelve month high of $177.40.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.08. The business had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.42 billion. Zoetis had a net margin of 28.21% and a return on equity of 57.19%. The company’s quarterly revenue was up .5% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.58 earnings per share. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Research analysts forecast that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 3rd. Shareholders of record on Tuesday, January 20th will be issued a $0.53 dividend. This is a boost from Zoetis’s previous quarterly dividend of $0.50. The ex-dividend date is Tuesday, January 20th. This represents a $2.12 annualized dividend and a yield of 1.7%. Zoetis’s payout ratio is presently 33.67%.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.